Order Article Reprints

Feng J, Hu M, Li Z, Hu G, Han Y, Zhang Y, Zhang M, Ren J. Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I–III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity. Cells. 2022; 11(16):2611. https://doi.org/10.3390/cells11162611

Feng, Junkai, Menglong Hu, Zongkuo Li, Guiming Hu, Yuting Han, Yan Zhang, Min Zhang, and Jingli Ren. 2022. "Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I–III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity" Cells 11, no. 16: 2611. https://doi.org/10.3390/cells11162611

Feng, J., Hu, M., Li, Z., Hu, G., Han, Y., Zhang, Y., Zhang, M., & Ren, J. (2022). Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I–III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity. Cells, 11(16), 2611. https://doi.org/10.3390/cells11162611